- Qualitative analysis that allows the detection of DPYD alleles:
- DPYD*2A [NM_000110.4: c.1905+1G>A (rs3918290)]
- DPYD*13 [NM_000110.4: c.1679T>G (rs55886062)]
- DPYD*hapB3 [NM_000110.4: c.1129-5923C>G (rs75017182)]
- DPYD-D949V [NM_000110.4: c.2846A>T (rs67376798)
- Pharmacogenetic analysis associated with the response to fluoropyrimidine chemotherapy treatments, such as 5-fluorouracil (5-FU) and its prodrugs capecitabine and tegafur, offering an optional guide for dose adjustment in each case.
- High sensitivity and specificity: The detection limit of 1 ng of genomic DNA.
- Includes a heterozygous positive control for each of the variants of interest.
- Validated using genomic DNA samples previously analyzed by sequencing techniques.
- For in vitro diagnostic use only, aimed at professionals in the field of molecular biology.
Through ClientSite you can filter variants and download your reports